Aug 18, 2022 / 05:30AM GMT
Operator
Good morning, ladies and gentlemen, and welcome to Q1 FY23 earnings conference call of SMS Pharmaceuticals Limited.
This conference call may contain forward-looking statements about the company, which are based on the beliefs, opinions, and expectations of the company as on date of this call. These statements are not the guarantees of future performance and involve risks and uncertainties that are difficult to predict.
(Operator Instructions) Please note that this conference is being recorded.
I now hand the conference over to Mr. Vamsi Krishna Potluri, Executive Director, at SMS Pharmaceuticals Limited. Thank you. And over to you, sir.
Vamsi Potluri - SMS Pharmaceuticals Limited - Executive Director
Good morning, everyone. Thank you for joining the earnings conference call to discuss the financial performance for the quarter ended June 30, 2022. I hope everyone must have got an opportunity to go through our financial results and the investor presentation, which has been uploaded on the stock exchange as well as our company website.
Q1 2023 SMS Pharmaceuticals Ltd Earnings Call Transcript
Aug 18, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers